Empery Asset Management, LP 13D and 13G filings for Moleculin Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-20 11:14 am Sale |
2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
Empery Asset Management, LP | 33,223 4.570% |
-8,444 (-20.27%) |
Filing |